E. Fischer

发表

Improving adrenal venous sampling in primary aldosteronism

M. Reincke, E. Fischer, C. Degenhart, 2012, Expert review of endocrinology & metabolism.

Atrial and ventricular septal defects can safely be closed by percutaneous intervention.

R. Hein, H. Sievert, N. Wilson, 2005, Journal of interventional cardiology.

Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder).

N. Wunderlich, R. Hein, H. Sievert, 2008, The American journal of cardiology.

Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.

S. Bertog, N. Wunderlich, H. Sievert, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Transcatheter Closure of Patent Foramen Ovale Without an Implant: Initial Clinical Experience

N. Wunderlich, H. Sievert, E. Fischer, 2007, Circulation.

Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays

A. Morganti, M. Bidlingmaier, S. Diederich, 2015, Journal of hypertension.

Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.

F. Beuschlein, B. Allolio, M. Quinkler, 2012, European journal of endocrinology.

Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry

R. Holle, C. Meisinger, F. Beuschlein, 2012, Hypertension.

The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.

S. Trerotola, L. S. Schultze Kool, J. Widimský, 2012, The Journal of clinical endocrinology and metabolism.

Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.

F. Beuschlein, M. Bidlingmaier, J. Seissler, 2013, The Journal of clinical endocrinology and metabolism.

Novel genes in primary aldosteronism

F. Beuschlein, E. Fischer, 2014, Current opinion in endocrinology, diabetes, and obesity.

Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism.

M. Reiser, F. Beuschlein, M. Bidlingmaier, 2014, The Journal of clinical endocrinology and metabolism.

Assay Characteristics Influence the Aldosterone to Renin Ratio as a Screening Tool for Primary Aldosteronism: Results of the German Conn’s Registry

M. Bidlingmaier, S. Hahner, M. Quinkler, 2013, Hormone and Metabolic Research.

PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.

P. Neužil, P. Serruys, P. Brugada, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Coexisting Prolactinoma and Primary Aldosteronism: Is There a Pathophysiological Link?

F. Beuschlein, M. Bidlingmaier, J. Schopohl, 2015, The Journal of clinical endocrinology and metabolism.

Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy.

S. Ito, F. Veglio, P. Mulatero, 2014, The Journal of clinical endocrinology and metabolism.

Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.

F. Beuschlein, T. Mussack, M. Bidlingmaier, 2013, European journal of endocrinology.

Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone.

F. Beuschlein, M. Bidlingmaier, S. Gerum, 2012, Journal of psychiatric research.

Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy.

F. Beuschlein, T. Mussack, M. Bidlingmaier, 2012, The Journal of clinical endocrinology and metabolism.

Spontaneous remission of idiopathic aldosteronism after long‐term treatment with spironolactone: results from the German Conn’s Registry

F. Beuschlein, M. Bidlingmaier, M. Reincke, 2012, Clinical endocrinology.

Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism

F. Beuschlein, X. Jeunemaître, M. Zennaro, 2012, Hypertension.

KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism

T. Strom, F. Beuschlein, X. Jeunemaître, 2012, Hypertension.

CT mapping of the vertebral level of right adrenal vein.

M. Reiser, M. Bidlingmaier, S. Wirth, 2015, Diagnostic and interventional radiology.

Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates.

F. Beuschlein, M. Bidlingmaier, U. Linsenmaier, 2011, European journal of endocrinology.

Diagnostik einer endokrinen Hypertonie: Wann screenen, und mit welchem Test?

F. Beuschlein, M. Reincke, E. Fischer, 2011, Deutsche medizinische Wochenschrift.

[Incidentaloma and subclinical disorders of the adrenal gland].

F. Beuschlein, E. Fischer, 2013, Deutsche medizinische Wochenschrift.

P. Neužil, P. Serruys, P. Brugada, 2010 .

A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population.

W. Lieb, F. Beuschlein, H. Wallaschofski, 2014, The Journal of clinical endocrinology and metabolism.

Sleep quality in patients with primary aldosteronism.

F. Beuschlein, B. Allolio, M. Quinkler, 2013, Hormones.

Sleep quality in patients with primary aldosteronism

F. Beuschlein, B. Allolio, M. Quinkler, 2014, Hormones.

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension

T. Wieland, T. Meitinger, T. Strom, 2013, Nature Genetics.

The Prevalence of Familial Hyperaldosteronism in Apparently Sporadic Primary Aldosteronism in Germany: a Single Center Experience

F. Beuschlein, M. Reincke, M. Morak, 2012, Hormone and Metabolic Research.

Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study

F. Beuschlein, M. Bidlingmaier, S. Gerum, 2014, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Shock late after implantation of a permanent transvenous cardiac pacemaker.

R. Collins, E. Fischer, D. Bogart, 1985, The American journal of cardiology.

Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism

F. Beuschlein, M. Bidlingmaier, M. Reincke, 2011, Reviews in Endocrine and Metabolic Disorders.

Spontaneous remission of idiopathic aldosteronism after long‐term treatment with spironolactone: results from the German Conn’s Registry

F. Beuschlein, M. Bidlingmaier, M. Reincke, 2012, Clinical endocrinology.

KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism

T. Strom, F. Beuschlein, X. Jeunemaître, 2012, Hypertension.

625 FULLY AUTOMATED CHEMILUMINESCENCE IMMUNOASSAYS FOR RENIN AND ALDOSTERONE: CLINICAL VALIDATION DURING THE SALINE-INFUSION TEST

M. Bidlingmaier, S. Diederich, M. Reincke, 2012 .

Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism: Results of the Else Kröner-Fresenius Hyperaldosteronismus Registry

M. Reiser, F. Beuschlein, M. Bidlingmaier, 2014 .

Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.

F. Beuschlein, B. Allolio, M. Quinkler, 2012, European journal of endocrinology.